Karyopharm 8K Filing
Karyopharm Therapeutics files 8K with SEC, disclosing changes in executive compensation and shareholder vote results. The filing also includes financial statements and exhibits.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.